Keywords: vivus, actis, cleared, otc, use, shares, erectile

Vivus' Actis cleared for OTC use

Article | 02 January 2001

Print This

Shares in erectile dysfunction specialist Vivus surged after the firmsaid it had been granted US approval to sell its Actis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in